<DOC>
	<DOCNO>NCT01850056</DOCNO>
	<brief_summary>The purpose study determine whether DEB effective common PTA balloon long-term vessel patency inhibit restenosis .</brief_summary>
	<brief_title>AcoArt â…  / SFA China</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Age 18 80 year Patients peripheral artery disease ( PAD ) , Rutherford classification 2 5 occlusion minimum grade stenosisPrimary 70 % superficial femoral artery /or popliteal artery Total length treat lesion ( ) less equal 40cm sign Patient inform consent form plasma Cr level great 150 umol/L patient patient acute thrombosis require lysis thrombectomy patient lysis lower limb intervention therapy within last 6 week patient require intervention low limbs time target lesion ca n't cross guide wire distal outflow less one low leg vessel know hypersensitivity aspirin , heparin , clopidogrel , paclitaxel , contrast medium , etc . patient participate another clinical trial interfere trial past 3 month pregnancy lactate woman untreatable bleeding diatheses disease , cancer , liver disease , cardiac insufficiency , may lead protocol violation markedly shorten patient 's life expectancy ( less 2 year ) patient unable unwilling participate trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>drug elute balloon catheter</keyword>
</DOC>